Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues

Neuropeptides

Volumn 31, Issue 5, 1997, Pages 409-413

  Vertongen, P ^a   De Clerck, P ^b   Fournet, J C ^c   Martelli, H ^c   Helardot P ^e   Devalck, C ^d   Peeters, T ^b   Sariban, E ^d   Robberecht, P ^a,f  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

^f Bât G E   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CHILD; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERNER MORRISON SYNDROME;

EID: 0030777078     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90033-0     Document Type: Article

References (26)

1. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept 1992; 37: 287-303.
2. Arimura A, Somogyvári-Vigh A, Miyata, A, Mizuno K, Coy DH, Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 1991; 129: 2787-2789.
3. Vertongen P, Woussen-Colle MC, Cauvin A, Robberecht P, Christophe J. Distribution of PACAP-38 and PACAP-27 in rat brain. Biomed Res 1992; 13: 377-382.
4. Rawlings SR, Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr Rev 1996; 17: 4-29.
5. Usdin TB, Bonner T I, Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994; 135: 2662-2680.
6. Chatterjee TK, Sharma RV, Fisher RA. Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels. J Biol Chem 1996; 271: 32226-32232.
7. Vertongen P, Devalck C, Sariban E et al. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas. J Cell Physiol 1996; 167: 36-46.
8. O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul Pept 1992; 37: 213-226.
9. 1 and chimeric N-terminal PACAP/VIP, receptors: evidences for multiple receptor states. Mol Pharmacol 1996; 50: 1596-1605.
10. Long RG, Bryant MG, Vasoactive intestinal polypeptide. In: Bloom SR, Long RG, eds. Radioimmunoassay of Gut Regulatory Peptides. London: WB Saunders, 1982: 120-130.
11. Hosoya M, Kimura, C, Ogi K et al. Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta 1992; 1129: 199-206.
12. Itoh N, Obata K, Yanaihara N, Okamoto H. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27 Nature 1983; 304: 547-549.
13. Ogi K, Miyamoto Y, Masuda Y et al. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor. Biochem Biophys Res Commun 1993; 196: 1511-1521.
14. Sreedharan SP, Patel DR, Huang J-X, Goetzl EJ. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem Biophys Res Commun 1993; 193: 546-553.
15. Svoboda M, Tastenoy M, Van Rampelbergh J et al. Molecular cloning and functional characterization of a human VIP receptor from SUP-Tl lymphoblasts. Biochem Biophys Res Commun 1994; 205: 1617-1624.
16. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 1974; 58: 541-548.
17. Modlin IM, Bloom SR. VIPomas and the watery diarrhoea syndrome. S Afr Med J 1978; 54: 53-56.
18. Laburthe MC, Dupont CM, Besson JD, Rousset M, Rosselin GE. A new bioassay of VIP: results in watery diarrhoea syndrome. Gut 1980; 21: 619-623.
19. Tiedemann K, Pritchard J, Long R, Bloom S R. Intractable diarrhoea in a patient with vasoactive intestinal peptidesecreting neuroblastoma. Eur J. Pediatr 1981; 137: 217-219.
20. Mendelsohn G, Eggleston JC, Olson JL, Said SI, Baylin SB. Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors. Lab Invest 1979; 41: 144-149.
21. Couvineau A, Rouyer-Fessard C, Fournier A, St-Pierre S, Pipkorn R, Laburthe M. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences. Biochem Biophys Res Commun 1984; 121: 493-498.
22. Wollman Y, Lilling G, Goldstein MN, Fridkin M, Gozes I. Vasoactive intestinal peptide: a growth promotor in neuroblastoma cells. Brain Res 1993; 624: 339-341.
23. Pence JF, Shorter NA. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res 1990; 50: 5177-5183.
24. Gressens P, Hill JM, Paindaveine B, Gozes I, Fridkin M, Brenneman D E. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J Clin Invest 1994; 94: 2020-2027
25. Yamagami T, Ohsawa K, Nishizawa M et al. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. In: Said. SI and Mutt V, eds. Vasoactive intestinal peptide and related peptides. Ann NY Acad Sci 1988; 527: 87-102.
26. Ohsawa K, Hayakawa Y, Nishisawa M et al. Synergistic stimulation of VIP/PHM-27 gene expression by cyclic AMP and phorbol esters in human neuroblastoma cells. Biochem Biophys Res Commun 1985; 132: 885-891.